Accelmed Partners raises $400m to invest in commercial stage healthtech

Accelmed Partners, a private equity firm focused on acquiring and investing in US commercial stage, lower middle market HealthTech companies, has closed its oversubscribed second fund, Accelmed Fund II at the fund’s hard cap of $400 million, exceeding its original $300 million target. Fund II received significant backing from new investors globally, including pension funds, […]